KPMG says that if proposed takeover of listed honey company fails then there is uncertainty as to how it will meet its debt obligations.
Strategic review of $460m stake in Australian medical imaging company under way.
The board of the dual-listed payment technology company has recommended that shareholders vote in favour of a deal to sell the company for $1.20 a share.
The company’s equity raise to recapitalise its balance sheet was oversubscribed, raising $23.9m.
Monday’s announcement of a $4.1m share purchase comes after the NZME director purchased $6.1m worth of shares in August.
The Medicare Administrative Contractor is setting up an expert panel to review coverage for tests, including for Cxbladder Triage.
New ANZ chief Nuno Matos continues to clear the decks and put the past behind him.
Two senior executives depart and several job titles adjust, with a chief operating officer to be appointed.
Locate Technologies says an NZX listing will remove restrictions and delays.
Listed telco infrastructure company's board in July recommended shareholders accept the 'low' offer from Tait Communications.